UVEX 750

Contents: Levofloxacin hemihydrate

Indications
:
Treatment of acute sinusitis, exacerbation of chronic bronchitis, community-acquired pneumonia, UTI & skin & soft tissue infections.

Dosage: Usual dose: 250-500 mg once or bid for 7-14 days. Acute bacterial sinusitis 500 mg daily for 10-14 days or 750 mg for 5 days. Uncomplicated & complicated acute bacterial exacerbation of chronic bronchitis 250-500 mg daily for 7-10 days or 750 mg for 3-5 days. Community-acquired pneumonia 500 mg once or bid for 7-14 days or 750 mg for 5 days. Nosocomial pneumonia 750 mg daily for 7-15 days. Skin & soft tissue infections 250 mg daily or 500 mg once or bid for 7-14 days. Complicated skin & skin structure infection 750 mg daily for 7-14 days. Uncomplicated UTI 250 mg once daily for 3 days. Complicated UTI (eg acute pyelonephritis) 250 mg daily for 7-10 days or 750 mg for 5 days. Chronic bacterial prostatitis 500 mg once daily for 28 days given in divided doses)

Administration
:
May be taken with or without food: Ensure adequate fluid intake.

Contraindications
:
Hypersensitivity to levofloxacin or other quinolones. Childn <18 yr.

Special Precautions
: Increased risk of tendinitis & tendon rupture especially in elderly >60 yr, in patients taking corticosteroids & those w/ kidney, heart or lung transplant. Pregnancy & lactation. Uvex 750 Contains tartrazine causing allergic reactions including bronchial asthma.

Adverse Drug Reactions
: Diarrhea, vomiting, abdominal pain, nausea, dyspepsia, rash, dizziness, headache, photosensitivity.

Drug Interactions
: May potentiate the anticoagulant effect of warfarin. Blood glucose disturbances including hyper- & hypoglycemia w/ antidiabetic agents. Decreased absorption
w/ antacids containing Al & Mg, Fe sulfate, sucralfate, metal cations eg Fe & multivit prep w/ Zn or didanosine.

Pregnancy Category (US FDA):
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.

MIMS Class:
Quinolones

ATC Classification
: J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.

Regulatory Classification: Rx

Form: Uvex 500 film-coated tab 500 mg, 10s;  Uvex 750 film-coated 750 mg, 10s
 
Reference: mims

Watch out for our new products. Coming out soon.

 
 
All Rights Reserved. Khriz Pharma. ©2014-2015